Eikon Therapeutics, Inc. (EIKN) Live Share Price, Invest From India

Eikon Therapeutics, Inc. Stock Performance

as on September 2, 2026 at 2:16 pm IST

Day's Low
$10.20
Day's Price Range
$10.88
$10.88
6.25%
Downside
52 Week's Low
52 Week's High
52-Week Price Range
$10.88
100.00%
Downside
-100.00%
Upside

Eikon Therapeutics, Inc. share price movements today

Previous Close: $10.46
Open: $10.31
Volume: 428.0K
Market Cap: $594.7M
Day's Low - High: $10.20 - $10.88

Eikon Therapeutics, Inc. Historical Returns

1 Month Return: + 18.13 %
3 Month Return: + 13.33 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Eikon Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Eikon Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$594.7M

EPS (TTM)

-6.4116

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-125.02%

Eikon Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eikon Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Eikon Therapeutics, Inc.	StrongBuy	$594.7M	NA	NA	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$137.9B	174.9%	31.92	86.04%	NA
Moderna	BUY	$61.6B	-61.21%	-7.98	-12.57%	NA
Regeneron	BUY	$82.3B	21.91%	19.9	84.86%	0.44%

Analyst Recommendation on Eikon Therapeutics, Inc. Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Eikon Therapeutics, Inc.. Average target price of $31

Indian Investors' Interest in Eikon Therapeutics, Inc. Stock

Search interest for Eikon Therapeutics, Inc. Stock has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 3, 2026 to September 2, 2026

Change:45% versus previous 30 day period

Eikon Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Mar 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-
Gross Profit	-	-	-5	-5
Operating Income	-67	-71	-83	-87
EBITDA	-	-	-74	-77
Interest Expense	0	-	0	-
Depreciation	6	6	5	5
Income Before Tax	-64	-68	-79	-82
Income Tax Expense	-	-	-	-
Net Income	-64	-68	-79	-82
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Eikon Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	-	-	-24
Operating Income	-265	-260	-338
EBITDA	-	-	-299
Interest Expense	0	0	0
Depreciation	17	25	24
Income Before Tax	-241	-243	-324
Income Tax Expense	-	-	-
Net Income	-241	-243	-324
Net Profit Margin	0.00%	0.00%	0.00%

Eikon Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-68	-79	-82	-88
Operating Cash Flow	-54	-41	-89	-64
Investing Cash Flow	-	40	-203	46
Financing Cash Flow	350	1	349	0
Change in Cash	81	0	56	-18

Eikon Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-243	-324
Operating Cash Flow	-134	-188
Investing Cash Flow	-	-181
Financing Cash Flow	0	352
Change in Cash	16	-17

Mutual Funds that own Eikon Therapeutics, Inc. Stock

Check out the Mutual Funds with significant holdings in Eikon Therapeutics, Inc..

Funds	Holdings	Shares Held
AB CAP FUND, INC.	0.906062%	490769
Principal Funds, Inc	0.256377%	138867
Franklin Strategic Series	0.235162%	127376
SCHWAB CAPITAL TRUST	0.025846%	14000

Global Institutional Holdings in Eikon Therapeutics, Inc.

Funds	Holdings
Vanguard	1.93%
iShares	1.5%
Felix Baker	1.03%
Stephen A. Schwarzman	0.31%
Schwab	0.21%

See all

Insights on Eikon Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, EIKN stock has moved down by -9.2%

About Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.

Organisation	Eikon Therapeutics, Inc.
Headquarters	230 Harriet Tubman Way, Millbrae, CA, United States, 94030
Industry	Biotechnology
CEO	Dr. Roger M. Perlmutter M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Eikon Therapeutics, Inc.

Name	Title
Ms. Barbara Howes M.B.A.	Chief People Officer
Mr. Michael A. Klobuchar	Chief Operating Officer
Dr. Robert Tjian Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Eric Betzig Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Alfred Lloyd Bowie Jr., Ph.D.	Treasurer & CFO
Mr. Russ Berman	Chief Technology Officer
Mr. Benjamin Bruno Thorner	Secretary, General Counsel & Chief Business Officer
Dr. Roger M. Perlmutter M.D., Ph.D.	Chairman, President & CEO
Dr. Roy D. Baynes FACP, M.D., Ph.D.	Executive VP & Chief Medical Officer

FAQs

What is Eikon Therapeutics, Inc. share price today?

Eikon Therapeutics, Inc. share price today is $10.88 as on September 2, 2026 at 8:46 am IST at the close of the market. Eikon Therapeutics, Inc. share today touched a day high of $10.88 and a low of $10.20.

What is the 52 week high and 52 week low for Eikon Therapeutics, Inc. share?

Eikon Therapeutics, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Eikon Therapeutics, Inc. stock price today i.e. September 2, 2026 at 8:46 am IST is closed at $10.88,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Eikon Therapeutics, Inc.'s market capitalisation today?

Eikon Therapeutics, Inc. market capitalisation is $0.00T as on September 2, 2026 at 8:46 am IST.

How to invest in Eikon Therapeutics, Inc. Stock (EIKN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eikon Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eikon Therapeutics, Inc. Shares that will get you 0.1379 shares as per Eikon Therapeutics, Inc. share price of $10.88 per share as on September 2, 2026 at 8:46 am IST.

What is the minimum amount required to buy Eikon Therapeutics, Inc. Stock (EIKN) from India?

Indian investors can start investing in Eikon Therapeutics, Inc. (EIKN) shares with as little as ₹94.96 or $1 (as of September 2, 2026 at 6:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Eikon Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 2, 2026 at 6:45 pm IST). Based on Eikon Therapeutics, Inc. share’s latest price of $10.88 as on September 2, 2026 at 8:46 am IST, you will get 0.9191 shares of Eikon Therapeutics, Inc.. Learn more about fractional shares .